In view of our finding that the FOS expression vector can selectively express target genes in glioma cells, we engineered a therapeutic cfos-TK adenovirus system that drives expression of HSV-tk and GFP (Ad-FOS-HSVtk-IRES- GFP; Fig 4A). Here, FOS is linked to central nervous system cancer.